CAP-2.1

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameCAP-2.1
Drug Alias NameCEACAM1 recombinant protein (CellAct Pharma/MGH)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionCarcinoembryonic antigen related cell adhesion molecule 1 modulators
TargetsCarcinoembryonic antigen related cell adhesion molecule 1
Therapy Area/IndicationsColitisArthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCellact Pharma Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsColitisArthritis

Other Information

ATC CodeN/A
Related LinksN/A